KIND: Anxiety
Course

KIND: Anxiety

Time limit: 360 days

$150 Enroll

Full course description

The Anxiety chapter guides professionals through the complexities of anxiety in children, including epidemiology, screening, and differential diagnosis. Topics cover anxiety’s presentation across age groups, distinctions from developmentally appropriate worries, and approaches tailored to neurodiverse and medically complex patients. Treatment sections review evidence-based nonpharmacological and pharmacological options, along with specialized strategies for conditions like OCD and epilepsy. This chapter equips clinicians with the knowledge to support children facing a range of anxiety-related challenges, fostering long-term well-being.

The Anxiety Chapter spans 35 topics across five levels of instruction. Levels 1 and 2 provide foundational knowledge beneficial for medical professionals and allied professionals, including educators, social workers, therapists, and psychologists.

Levels 3 to 5 shift to a more clinical focus, offering advanced insights geared toward medical doctors and sub-specialists.

The table below outlines the complete chapter content.

 

Chapter Editors

 

Joyce Harrison, MD serves as staff psychiatrist at the Psychiatric Mental Health Program at Kennedy Krieger Institute, with special interest in infant and preschool psychiatry.   She is the Project Director for Kennedy Krieger Institutes Network for Early Childhood Tele-education (KKI-NECT), which provides tele-consultation for pediatric primary care providers in rural and underserved areas.  She also serves as an assistant professor of psychiatry at The Johns Hopkins University School of Medicine. Dr. Harrison’s research interests focus on infant and preschool mental health training and interventions, school and community-based services, and behavioral health integration into primary care.

Nadia Ziam, MD is an Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins School of Medicine. Her expertise is centered around Child Psychiatry and Pediatrics.

Content, Featured Experts, and Learner Groups 

 

Level

Neurodevelopmental Topic Content

Featured Expert

Learner Group(s)

Level 1

1.1 Epidemiology of Pediatric Anxiety

Joyce Harrison, MD

Allied professionals

Medical Professionals

Sub-Specialist Professionals

1.2 A Primer on Common Anxiety Disorders

Joyce Harrison, MD

1.3 Generalized Anxiety Disorder

Aime Bettencourt, Ph.D.

1.4 Separation Anxiety Disorder

Aime Bettencourt, Ph.D.

1.5 Obsessive-Compulsive Disorder

Marco Grados, MD, MPH

1.6 A Primer on Less Common Anxiety Disorders

Joyce Harrison, MD

1.7 Distinguishing Anxiety from Developmentally Appropriate Worries

Nadia Ziam, MD

Level 2

2.1 Presenting Symptoms by Age

Lauren Burton, MD

Allied professionals

Medical Professionals

Sub-Specialist Professionals

2.2 Screening and Assessment

Raghad Alkhafaji, MD

2.3 Differential Diagnosis

Bradley Grant, DO

Level 3

3.1 Anxiety in Neurodiverse Patients

Amy Keefer, PhD, ABPP

Medical Professionals

Sub-Specialist Professionals

3.2 Anxiety in Medically Complex Patients

Nadia Ziam, MD

Level 4

4.1 Review of the Evidence

Hal Kronsberg, MD

Medical Professionals

Sub-Specialist Professionals

4.2 Nonpharmacological Approaches

Aime Bettencourt, Ph.D.

4.3 Medications

Marco Grados, MD, MPH

4.4 Medications and Therapy in OCD

Marco Grados, MD, MPH

4.5 Treatment Considerations in Neurodiverse Populations

Roma Vasa, MD

4.6 Treatment Considerations in Medically Complex Patients

Nadia Ziam, MD

4.7 Treatment Considerations in Patients with Epilepsy

Jay Salpekar, MD, FANPA

Level 5

5.1 Natural History and Outcomes/Long Term Follow-Up

Joyce Harrison, MD

Medical Professionals

Sub-Specialist Professionals

What is the KIND Curriculum?

 

 

 

Terms of Use & Privacy Policy

The Terms of Use and Privacy Policy set forth on the Kennedy Krieger Institute website apply to any and all uses of and access to this site and the content found here.


The learning materials contained in the KIND Curriculum (“Learning Materials”) include publicly available medical evidence, expert opinion, and the experiential knowledge of the subject matter experts identified in the KIND Curriculum.

 

The Learning Materials are intended only to provide general information and need to be adapted for individualized patient care based on each practitioners’ professional judgment, unique patient circumstances, and other pertinent factors. The Learning Materials are not intended to constitute general medical advice or treatment or advice or treatment for any particular patient. The Learning Materials are not intended to create a doctor-patient relationship between/among Kennedy Krieger Institute, its physicians and individual patients or their family members or caregivers. Kennedy Krieger Institute makes no warranty, expressed or implied, with respect to the currency, completeness, applicability, or accuracy of the Learning Materials.

To the extent that the Learning Materials include information regarding drug dosing, every effort will be made to identify when drug or medical device information included in the Learning Materials is not in agreement with FDA approval or guidance. However, it is the responsibility of the practitioner to ascertain FDA dosing recommendations and approval status of prescribed drugs and devices in their clinical practices. 


Kennedy Krieger Institute and its employees and agents are not responsible for errors or omissions in the Learning Materials.  Each professional practitioner caring for a patient is solely and exclusively responsible for the patient care of such patient.

 

The Learning Materials are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Learning Materials may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.